Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2574425 | Vascular Pharmacology | 2010 | 9 Pages |
Abstract
Thyroid hormone (TH), apart from its “classical” actions on cardiac contractility and heart rhythm, appears to regulate various intracellular signalling pathways related to response to stress and cardiac remodelling. There is now accumulating experimental and clinical evidence showing a beneficial effect of TH on limiting myocardial ischaemic injury, preventing/reversing post infarction cardiac remodelling and improving cardiac hemodynamics. Thyroid analogs have already been developed and may allow TH use in clinical practice. However, the efficacy of TH in the treatment of cardiac diseases is now awaiting to be tested in large clinical trials.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Constantinos Pantos, Iordanis Mourouzis, Dennis V. Cokkinos,